Alliancebernstein L.P. Acquires 101,560 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Alliancebernstein L.P. grew its holdings in Phibro Animal Health Co. (NASDAQ:PAHC) by 357.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 130,000 shares of the company’s stock after acquiring an additional 101,560 shares during the quarter. Alliancebernstein L.P. owned 0.32% of Phibro Animal Health worth $2,730,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Quantbot Technologies LP boosted its holdings in Phibro Animal Health by 65.1% in the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company’s stock valued at $107,000 after purchasing an additional 2,018 shares during the period. Meeder Asset Management Inc. acquired a new stake in Phibro Animal Health during the fourth quarter worth about $113,000. New York State Teachers Retirement System increased its stake in Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after acquiring an additional 775 shares during the period. Amundi raised its holdings in Phibro Animal Health by 185.5% in the 4th quarter. Amundi now owns 9,855 shares of the company’s stock valued at $212,000 after acquiring an additional 6,403 shares in the last quarter. Finally, SG Americas Securities LLC raised its holdings in Phibro Animal Health by 7.4% in the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock valued at $276,000 after acquiring an additional 906 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Stock Down 6.1 %

Shares of NASDAQ PAHC opened at $16.81 on Wednesday. The business has a fifty day moving average of $21.95 and a two-hundred day moving average of $22.39. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. Phibro Animal Health Co. has a 52-week low of $12.30 and a 52-week high of $26.55. The stock has a market cap of $680.97 million, a PE ratio of 35.02, a PEG ratio of 0.45 and a beta of 0.63.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, equities research analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were given a $0.12 dividend. The ex-dividend date was Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 2.86%. Phibro Animal Health’s payout ratio is 100.00%.

Wall Street Analysts Forecast Growth

PAHC has been the topic of a number of research reports. Morgan Stanley boosted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Barclays boosted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Finally, StockNews.com downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Tuesday, March 25th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $21.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.